Molecular and genetic characterization of hepatitis B virus among multitransfused thalassaemia patients in Islamabad, Pakistan
- PMID: 34041111
- PMCID: PMC8138360
- DOI: 10.4103/jfmpc.jfmpc_1880_20
Molecular and genetic characterization of hepatitis B virus among multitransfused thalassaemia patients in Islamabad, Pakistan
Abstract
Background: Hepatitis B virus (HBV) is the aetiological agent of transfusion-transmitted hepatitis globally. Beta thalassaemia major individuals are at greater risk of contracting HBV infection due to multiple blood transfusions required for the medical management of these patients. Based on HBV genetic variability, it is divided into 10 genotypes. The determination of HBV genotypes has significant implications for clinical management and treatment regimens.
Aim: This study was performed to assess the HBV epidemiology and circulating genotypes in multi-transfused β-thalassemia major patients with the aim to be considered while formulating the treatment pattern taking into account particular needs of thalassaemia patients.
Materials and methods: This study was performed from September 2018 to June 2019, at the Department of Pathology and Transfusion Medicine, Shaheed Zulfiqar Ali Bhutto (SZAB) Medical University, Islamabad. A total of 2,260 thalassaemia patients were enrolled in the study. The study was endorsed by the Ethics Committee of the SZAB Medical University, Islamabad. The samples were serologically screened for HBsAg on the LIAISON® XL Murex HBsAg Quant assay (DiaSorin S.p.A., Italy) a chemiluminescence based immunoassay (CLIA). HBV quantitative PCR kit was used to measure the HBV DNA in serum samples. The HBV genotypes were determined using universal primers targeting the P1 and S1 region amplification.
Results: Of 2,260 thalassaemia patients, 64.6% were males while 35.4% were females. The HBsAg was identified in 98 individuals (4.33%). The PCR analysis was done for these 98 patients and in this cohort, genotype D was 59.18% (n = 58), genotype A was 21.42% (n = 21) while genotype C was 19.38% (n = 19).
Conclusion: The determination of HBV genotypes in the multi-transfused patients is key to the effective management of chronic HBV patients as the severity and course of the disease is dependent on a specific type of genotypes. Quality assured screening of donated blood will prevent the incidence of HBV in thalassaemia patients.
Keywords: Epidemiology; HBV; Pakistan; genotype; polymerase chain reaction; thalassaemia.
Copyright: © 2021 Journal of Family Medicine and Primary Care.
Conflict of interest statement
There are no conflicts of interest.
Figures


Similar articles
-
Epidemiology of Transfusion Transmitted Infection among Patients with β-Thalassaemia Major in Pakistan.J Blood Transfus. 2016;2016:8135649. doi: 10.1155/2016/8135649. Epub 2016 Jul 31. J Blood Transfus. 2016. PMID: 27559490 Free PMC article.
-
Molecular epidemiology of hepatitis B virus genotypes in blood donors in Islamabad, Pakistan.J Lab Physicians. 2019 Jul-Sep;11(3):240-243. doi: 10.4103/JLP.JLP_150_18. J Lab Physicians. 2019. PMID: 31579261 Free PMC article.
-
Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.J Clin Virol. 2014 Jan;59(1):44-9. doi: 10.1016/j.jcv.2013.10.009. Epub 2013 Nov 7. J Clin Virol. 2014. PMID: 24268764
-
Detection of HBsAg mutants in the blood donor population of Pakistan.PLoS One. 2017 Nov 22;12(11):e0188066. doi: 10.1371/journal.pone.0188066. eCollection 2017. PLoS One. 2017. PMID: 29166662 Free PMC article.
-
Evaluation of screening effectiveness of hepatitis B surface antigen and anti-HCV rapid test kits in Pakistan.J Lab Physicians. 2019 Oct-Dec;11(4):369-372. doi: 10.4103/JLP.JLP_172_19. J Lab Physicians. 2019. PMID: 31929706 Free PMC article.
Cited by
-
A Recent Prevalence of Hepatitis B Virus (HBV) Genotypes and Subtypes in Asia: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2023 Apr 1;11(7):1011. doi: 10.3390/healthcare11071011. Healthcare (Basel). 2023. PMID: 37046937 Free PMC article. Review.
References
-
- WHO. Hepatitis B – Key Facts. [Last accessed on 2020 Jan 27]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b .
-
- Haiyong J, Diwakar R, Peng Z, Xuwang C, Xuemei J, Xinyong L. Recent advance of the hepatitis B virus inhibitors: A medicinal chemistry overview. Future Med Chem. 2015;7:587–607. - PubMed
-
- Zaheer HA, Waheed U, Abdella YE, Konings F. Thalassaemia in Pakistan: A forward looking solution to a serious health issue. Glob J Transfus Med. 2020;5:108–10.
-
- Mohammad J, Hussain M, Khan MA. Frequency of hepatitis B and hepatitis C infection in thalassemic children. Pak Pediatr J. 2003;27:161–4.
LinkOut - more resources
Full Text Sources
Other Literature Sources